China Closely Following Russia’s Progress in Clinical Trials of COVID Vaccines, Ambassador Says

MOSCOW (Sputnik) – China is intently following Russia’s progress in scientific trials of vaccines in opposition to COVID-19 and hopes that their use will assist in stopping and controlling the epidemic in Russia, Chinese ambassador to Russia Zhang Hanhui mentioned.

“We are closely following the latest progress of the Russian side in clinical trials of vaccines. We are confident that successful research and development of vaccines and their widespread use will play an important role in the successful prevention and control of the epidemic in Russia,” Zhang mentioned.

The diplomat additionally praised Moscow-Beijing coordination in the sphere of public well being amid the pandemic and mentioned that China favors the additional strengthening of cooperation in varied analysis fields.

Russia has been among the many leaders of COVID-19 vaccine improvement with two of its merchandise, Sputnik V, created by Moscow’s Gamaleya Institute, and EpiVacCorona, by the Siberian analysis heart Vector, already in the Phase 3 trials.


Related posts